Compare GNLX & LFMDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNLX | LFMDP |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | 26 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.1M | N/A |
| IPO Year | 2022 | 2012 |
| Metric | GNLX | LFMDP |
|---|---|---|
| Price | $2.72 | $23.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | ★ 318.4K | 1.9K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.47 | ★ 141.67 |
| EPS | N/A | ★ N/A |
| Revenue | $8,000.00 | ★ $12,468,578.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | $2.29 | $18.50 |
| 52 Week High | $8.54 | $24.20 |
| Indicator | GNLX | LFMDP |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 40.35 |
| Support Level | $2.39 | $22.90 |
| Resistance Level | $3.02 | $23.24 |
| Average True Range (ATR) | 0.20 | 0.12 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 52.33 | 0.00 |
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.